Literature DB >> 24656386

Comparative analysis of different oral approaches to treat Vibrio cholerae infection in adult mice.

Abhishek Jaiswal1, Hemanta Koley1, Soma Mitra1, Dhira Rani Saha1, Banwarilal Sarkar2.   

Abstract

In this study, we have established an oral phage cocktail therapy in adult mice model and also performed a comparative analysis between phage cocktail, antibiotic and oral rehydration treatment for orally developed Vibrio cholerae infection. Four groups of mice were orally infected with Vibrio cholerae MAK 757 strain. Phage cocktail and antibiotic treated groups received 1×10(8) plaque forming unit/ml (once a daily) and 40mg/kg (once a daily) as an oral dose respectively for consecutive three days after bacterial infection. In case of oral rehydration group, the solution was supplied after bacterial infection mixed with the drinking water. To evaluate the better and safer approach of treatment, tissue and serum samples were collected. Here, phage cocktail treated mice reduced the log10 numbers of colony per gram by 3log10 (p<0.05); however, ciprofloxacin treated mice reduced the viable numbers up to 5log10 (p<0.05). Whereas, the oral rehydration solution application was not able to reduce the viable bacterial count but the disease progress was much more diminished (p>0.05). Besides, it was evident that antibiotic and phage cocktail treated group had a gradual decrease in both IL-6 and TNF-α level for 3 days (p<0.05) but the scenario was totally opposite in bacterial control and oral hydration treated group. Histological examinations also endorsed the phage cocktail and ciprofloxacin treatment in mice. Although, in this murine model of cholera ciprofloxacin was found to be a better antimicrobial agent, but from the safety and specificity point of view, a better method of application could fill the bridge and advances the phages as a valuable agent in treating Vibrio cholerae infection.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Lytic; Oral administration; Phage cocktail; Vibrio cholerae; Vibriophage

Mesh:

Substances:

Year:  2014        PMID: 24656386     DOI: 10.1016/j.ijmm.2014.02.007

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  10 in total

Review 1.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

Review 2.  Biological challenges of phage therapy and proposed solutions: a literature review.

Authors:  Katherine M Caflisch; Gina A Suh; Robin Patel
Journal:  Expert Rev Anti Infect Ther       Date:  2019-12-02       Impact factor: 5.091

3.  In vitro Digestion Characteristics of Hydrolyzed Infant Formula and Its Effects on the Growth and Development in Mice.

Authors:  Lifang Feng; Wei Ye; Kuo Zhang; Daofeng Qu; Weilin Liu; Min Wu; Jianzhong Han
Journal:  Front Nutr       Date:  2022-06-24

Review 4.  Cholera: an overview with reference to the Yemen epidemic.

Authors:  Ali A Rabaan
Journal:  Front Med       Date:  2018-06-22       Impact factor: 4.592

5.  Genetic Basis of High-Pressure Tolerance of a Vibrio parahaemolyticus Mutant and Its Pathogenicity.

Authors:  Lifang Feng; Minhui Xu; Junli Zhu; Haixia Lu
Journal:  Front Microbiol       Date:  2022-03-31       Impact factor: 5.640

Review 6.  Insights into Bacteriophage Application in Controlling Vibrio Species.

Authors:  Vengadesh Letchumanan; Kok-Gan Chan; Priyia Pusparajah; Surasak Saokaew; Acharaporn Duangjai; Bey-Hing Goh; Nurul-Syakima Ab Mutalib; Learn-Han Lee
Journal:  Front Microbiol       Date:  2016-07-19       Impact factor: 5.640

7.  A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models.

Authors:  Minmin Yen; Lynne S Cairns; Andrew Camilli
Journal:  Nat Commun       Date:  2017-02-01       Impact factor: 14.919

8.  Isolation and Characterization of Novel Broad Host Range Bacteriophages of Vibrio cholerae O1 from Bengal.

Authors:  Sounak Sarkar; Mayukh Das; Tushar Suvra Bhowmick; Hemanta Koley; Robert Atterbury; Alok K Chakrabarti; Banwarilal L Sarkar
Journal:  J Glob Infect Dis       Date:  2018 Apr-Jun

Review 9.  Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System.

Authors:  Jonas D Van Belleghem; Krystyna Dąbrowska; Mario Vaneechoutte; Jeremy J Barr; Paul L Bollyky
Journal:  Viruses       Date:  2018-12-25       Impact factor: 5.048

Review 10.  Animal Models of Phage Therapy.

Authors:  Samuel Penziner; Robert T Schooley; David T Pride
Journal:  Front Microbiol       Date:  2021-01-28       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.